J3380 HCPCS Level II code: Injection, vedolizumab, intravenous, 1 mg
J3380 is the HCPCS code for “Injection, vedolizumab, intravenous, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3380Injection, vedolizumab, intravenous, 1 mg
Short description: Inj vedolizumab iv 1 mg
HCPCS · United States
Notes for J3380
As CMS prints them, with any note J3380 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J3380 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2016
Where J3380 sits
- 1J codesDrugs administered other than orally
- 2Active code J3380Injection, vedolizumab, intravenous, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3380 mean?
J3380 is the HCPCS code for “Injection, vedolizumab, intravenous, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3380?
CMS lists J3380’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3380
All J codesJ3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgJ3373Injection, vancomycin hydrochloride, 10 mgJ3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mgJ3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mgJ3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mgJ3379Injection, valproate sodium, 5 mgJ3385Injection, velaglucerase alfa, 100 unitsJ3386Injection, etuvetidigene autotemcel, per treatmentJ3387Injection, elivaldogene autotemcel, per treatmentJ3389Topical administration, prademagene zamikeracel, per treatmentJ3391Injection, atidarsagene autotemcel, per treatmentJ3392Injection, exagamglogene autotemcel, per treatment